Old Web
English
Sign In
Acemap
>
Paper
>
1152P Real-world outcomes in resected stage IB-IIIA EGFR mutated NSCLC in Canada: Analysis from the POTENT study
1152P Real-world outcomes in resected stage IB-IIIA EGFR mutated NSCLC in Canada: Analysis from the POTENT study
2021
M.S. Kuruvilla
I Syed
F. Gwadry Sridhar
R Sachdeva
A. Pencz
L. J. Zhan
Katrina Hueniken
Devalben Patel
K. Balaratnam
K. Khan
B. Grant
B. Sheffield
S. Noy
K.P. Singh
L. Liu
M. Ralibuz-Zaman
B. Davis
D. Moldaver
M Shanahan
Parneet Cheema
Keywords:
real world outcomes
Oncology
stage ib
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]